Table 1 Demographics and baseline disease characteristics

Total Patients

232

100%

Surgery done

08/02/91–12/13/12

Age at Diagnosis

 < 60

130

56%

 ≥ 60

102

44%

Median (Range)

58 (26–89)

 Tumor Histology

 Serous Carcinoma

160

69%

 Endometrioid Adenocarcinoma

21

9%

 Clear Cell Carcinoma

17

7%

 Mixed

15

6%

 Mucinous Carcinoma

13

6%

 MMMT

4

2%

 Undifferentiated

2

1%

Pathologic Stage

 I

50

22%

 II

18

8%

 III

140

60%

 IV

24

10%

Silberberg’s Grade

 1

27

12%

 2

28

12%

 3

177

76%

Received Chemotherapy

 No

16

7%

 Yes

216

93%

Residual Disease

 No

113

49%

 Yes

119

51%

Persistent Disease

 No

144

62%

 Yes

88

38%

LHR-I

 Negative

30

13%

 Weak

24

10%

 Moderate

26

11%

 Strong

152

66%

LHR-P

 0%

30

13%

 1–50%

4

2%

 >  50%

197

85%

Missing/LHR Intensity Negative

1